BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37169176)

  • 21. Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases.
    Cavaco D; Martins AF; Cabrera R; Vilar H; Leite V
    Eur Thyroid J; 2022 Jan; 11(1):. PubMed ID: 34981753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor- and progesterone receptor-positive diffuse sclerosing variant of papillary thyroid carcinoma: a case report.
    Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Emoto Y; Tsubura A; Shikata N
    Case Rep Oncol; 2013 Jan; 6(1):216-23. PubMed ID: 23626564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
    Holoubek SA; MacKinney EC; Khokar AM; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
    Surgery; 2022 Jan; 171(1):203-211. PubMed ID: 34384604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
    Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical Management of Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Experience in 25 Patients.
    Spinelli C; Strambi S; Bakkar S; Nosiglia A; Elia G; Bertocchini A; Calani C; Leoni M; Morganti R; Materazzi G
    World J Surg; 2020 Jan; 44(1):155-162. PubMed ID: 31605177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.
    Kim M; Cho SW; Park YJ; Ahn HY; Kim HS; Suh YJ; Choi D; Kim BK; Yang GE; Park IS; Yi KH; Jung CK; Kim BH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):619-627. PubMed ID: 34107674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Implication of Bilateral and Unilateral Multifocality in Papillary Thyroid Carcinoma: A Propensity Score-Matched Study.
    Kim Y; An S; Park J; Bae JS; Kim JS; Kim K
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution.
    Fukushima M; Ito Y; Hirokawa M; Akasu H; Shimizu K; Miyauchi A
    World J Surg; 2009 May; 33(5):958-62. PubMed ID: 19198928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse sclerosing variant of papillary thyroid carcinoma: a study of fine needle aspiration cytology in 20 patients.
    Takagi N; Hirokawa M; Nobuoka Y; Higuchi M; Kuma S; Miyauchi A
    Cytopathology; 2014 Jun; 25(3):199-204. PubMed ID: 23781895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
    Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
    Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival benefit of active surveillance for papillary thyroid carcinoma: a propensity score matching analysis based on SEER database.
    Bi J; Lyu PF; Wang Y; Zhang H
    Front Oncol; 2023; 13():1185650. PubMed ID: 37361590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Gross Extrathyroidal Extension to Strap Muscles (T3b) Only a Risk Factor for Recurrence in Papillary Thyroid Carcinoma? A Propensity Score Matching Study.
    Kim Y; Kim YS; Bae JS; Kim JS; Kim K
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score-matched analysis.
    Guo H; Zhang N; Hu Y; Zhang F; Huang T; Shen N
    Front Endocrinol (Lausanne); 2023; 14():1158581. PubMed ID: 37664843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
    Forleo R; Grani G; Alfò M; Zilioli V; Giubbini R; Zatelli MC; Gagliardi I; Piovesan A; Ragni A; Morelli S; Puxeddu E; Pagano L; Deandrea M; Ceresini G; Torlontano M; Puligheddu B; Antonelli A; Centanni M; Fugazzola L; Spiazzi G; Monti S; Rossetto R; Monzani F; Tallini G; Crescenzi A; Sparano C; Bruno R; Repaci A; Tumino D; Pezzullo L; Lombardi CP; Ferraro Petrillo U; Filetti S; Durante C; Castagna MG
    Thyroid; 2021 Dec; 31(12):1814-1821. PubMed ID: 34541894
    [No Abstract]   [Full Text] [Related]  

  • 36. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
    Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
    Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse sclerosing variant of papillary thyroid carcinoma: ultrasonographic and clinicopathological features in children/adolescents and adults.
    Wang Q; Chang Q; Zhang R; Sun C; Li L; Wang S; Wang Q; Li Z; Niu L
    Clin Radiol; 2022 May; 77(5):e356-e362. PubMed ID: 35197192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
    Genpeng L; Pan Z; Tao W; Rixiang G; Jingqiang Z; Zhihui L; Jianyong L
    Surgery; 2022 Feb; 171(2):368-376. PubMed ID: 34482990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine-needle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis; A potential pitfall: A case report and review of the literature.
    Bongiovanni M; Triponez F; McKee TA; Kumar N; Matthes T; Meyer P
    Diagn Cytopathol; 2009 Sep; 37(9):671-5. PubMed ID: 19373906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.